πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Patent portfolio

Regeneron Ireland Designated Patents

Full USPTO pharma patent portfolio for Regeneron Ireland Designated β€” grant dates, expiration, and drug cross-links.

Patents
8,292
Expiring ≀24m
426

Quick answer

Regeneron Ireland Designated has 8,292 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 426 expire within 24 months β€” use filters for patent-cliff planning.

Page 136 of 173

  1. US 7355079

    Thyronamine derivatives and analogs and methods of use thereof

    Expires Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7354928

    Small molecule inhibitors targeted at Bcl-2

    Expires Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7354912

    Unique compositions of zwitterionic phospholipids and bisphosphonates and use of the compositions as bisphosphate delivery systems with reduced GI toxicity

    Expires Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7354900

    Treatment and inhibition of ocular infections and wounds by CAP37 and CAP37 peptides

    Expires Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 7351739

    Bioactive compounds and methods of uses thereof

    Expires Mon Mar 27 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7351542

    Methods of modulating tubulin deacetylase activity

    Expires Mon Mar 27 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7351408

    Glycoconjugates and methods

    Expires Mon Mar 27 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7351830

    Pancratistatin cyclic phosphate prodrugs and phenpanstatin cyclic phosphate prodrugs

    Expires Mon Mar 27 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 7347987

    Inhibition of reactive oxygen species and protection of mammalian cells

    Expires Mon Mar 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7348153

    Method for identifying and designing immunogenic peptides

    Expires Mon Mar 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7344530

    Thermal surgical procedures and compositions

    Expires Mon Mar 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7344724

    UspA1 and UspA2 antigens of Moraxella catarrhalis

    Expires Mon Mar 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 7344722

    Cold-adapted influenza virus

    Expires Mon Mar 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7344829

    Methods for detecting the efficacy of anticancer treatments

    Expires Mon Mar 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 7344712

    Urinary tract tissue graft compositions and methods for producing same

    Expires Mon Mar 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7344531

    Thermal surgical procedures and compositions

    Expires Mon Mar 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7344703

    Mycobacterial sulfation pathway proteins and methods of use thereof

    Expires Mon Mar 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7342101

    Compositions and methods comprising a protective antigen of Coccidiodes immitis

    Expires Mon Mar 06 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7342046

    Gossypol co-crystals and the use thereof

    Expires Mon Mar 06 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7341871

    Nucleotide sequences for gene regulation and methods of use thereof

    Expires Mon Mar 06 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7341709

    Compositions for labeling Ξ²-amyloid plaques and neurofibrillary tangles

    Expires Mon Mar 06 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7339023

    Partial peptide mimetics and methods

    Expires Mon Feb 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7338798

    System and method for forming a cardiac muscle construct

    Expires Mon Feb 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7338758

    Compositions and methods for the identification, assessment, prevention and therapy of human cancers

    Expires Mon Feb 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7335744

    Prostate cancer specific internalizing human antibodies

    Expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7335640

    Administration of hypocretin-1 for treatment of narcolepsy

    Expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7335681

    Amino ceramide-like compounds and therapeutic methods of use

    Expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7335662

    Substituted tricyclic compounds as protein kinase inhibitors

    Expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7335679

    Wortmannin analogs and methods of using same

    Expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7335383

    Generation of nitric oxide in vivo from nitrite, nitrate or nitrosothiols endogenous in blood

    Expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7332469

    Intrapleural single-chain urokinase alone or complexed to its soluble receptor protects against pleural adhesions

    Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7332159

    Method and composition for inhibiting reperfusion injury in the brain

    Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7332224

    Cleaning article containing hydrophilic polymers

    Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7332298

    Nucleic acids encoding multimeric proteins of TNF superfamily ligands

    Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7332321

    Viral fibers

    Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7332470

    Methods and compositions for treating ocular disease

    Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7332527

    Cross-linked ionic core micelles

    Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7332585

    Bispecific single chain Fv antibody molecules and methods of use thereof

    Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7332287

    Methods and compositions for diagnosing breast cancer

    Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7329759

    Illudin analogs useful as antitumor agents

    Expires Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7329401

    Cyclooxygenase-2 selective agents useful as imaging probes and related methods

    Expires Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7329642

    Ξ²-2-glycoprotein is an inhibitor of angiogenesis

    Expires Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7329638

    Drug delivery compositions

    Expires Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7329511

    Nucleic acid encoding GAD65

    Expires Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7326712

    Substituted tricyclic compounds as protein kinase inhibitors

    Expires Mon Jan 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7326713

    Substituted tricyclic compound as protein kinase inhibitors

    Expires Mon Jan 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7326570

    Induction of tubular morphogenesis using pleiotrophin

    Expires Mon Jan 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7326734

    Treatment of bladder and urinary tract cancers

    Expires Mon Jan 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Regeneron Ireland Designated have?

8,292 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Regeneron Ireland Designated patents expire?

426 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.